GlassScriptPhysician profile
James R Webb
NPI 1487645800
$12,700.76
in general payments reported to CMS, 2019-2025
14 companies · $1,478 in 2025
The $1,478 reported for 2025 was more than what 88% of Diagnostic Radiology providers received nationally (typical 2025 total: $112).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $444 · 2020: $364 · 2021: $6,282 · 2022: $2,977 · 2023: $497 · 2024: $658 · 2025: $1,478.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,675 · Travel and Lodging: $944 · Gift: $15.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,674.68 |
| Travel and Lodging | $943.67 |
| Gift | $15.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Izi Medical Products, LLC | $9,307.16 | 2021-2024 | |
| Genesys Orthopedics Systems, L.L.C. | $1,222.59 | 2025 | Sacroiliac Joint Fusion System |
| Amgen INC. | $715.55 | 2019-2025 | Evenity, Prolia |
| Radius Health, INC. | $349.00 | 2019-2024 | Tymlos |
| Stryker Corporation | $322.95 | 2022-2024 | Augment Injectable |
| Boston Scientific Corporation | $205.28 | 2025 | Intracept |
| Penumbra, INC. | $177.00 | 2021 | |
| Medtronic USA, INC. | $143.88 | 2019-2020 | |
| Ucb, INC. | $108.75 | 2023 | |
| Edwards Lifesciences Corporation | $62.54 | 2024 | |
| Almatica Pharma LLC | $29.55 | 2025 | Teriparatide |
| Abbott Laboratories | $26.21 | 2021 | |
| Daiichi Sankyo INC. | $19.18 | 2019 | |
| Biodelivery Sciences International, INC. | $11.12 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Webb listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.